Gonadotropin-releasing hormone agonist to induce final oocyte maturation prevents the development of ovarian hyperstimulation syndrome in high-risk patients and leads to improved clinical outcomes compared with coasting
2010 ◽
Vol 94
(3)
◽
pp. 1111-1114
◽
2016 ◽
Vol 6
(3)
◽
pp. 85-89
2011 ◽
Vol 95
(6)
◽
pp. 2029-2033.e1
◽
2010 ◽
Vol 93
(7)
◽
pp. 2418-2420
◽
2016 ◽
Vol 8
(5)
◽
pp. 396-401
◽
2016 ◽
Vol 20
(4)
◽
pp. 246-250
◽
2010 ◽
Vol 28
(06)
◽
pp. 468-474
◽
2008 ◽
Vol 90
(3)
◽
pp. 876-878
◽
2015 ◽
Vol 32
(7)
◽
pp. 1063-1068
◽